Literature DB >> 1997493

Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data.

D A Rottenberg1, J R Moeller, S C Strother, V Dhawan, M L Sergi.   

Abstract

Although we and others have employed a thresholding strategy to extract "peak" values from positron emission tomographic (PET) regions of interest (ROIs), the effects of peak picking on fitted fluorodeoxyglucose rate constants, regional metabolic rate for glucose (rCMRglc) profiles, patterns of regional metabolic covariation, and PET-neurobehavioral correlations have not been systematically investigated. Our results suggest that under some commonly encountered imaging conditions percent thresholding may increase sensitivity to regional activation; however, the effect of thresholding is determined by a number of factors, including the relative magnitude of regional activation, ROI size, and the specific threshold selected. The difference-annulus concept is proposed as a means to study the effects of different region drawing and thresholding strategies, and to determine if a given ROI contains one and only one source of covarying metabolic activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997493     DOI: 10.1038/jcbfm.1991.42

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  6 in total

1.  Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease.

Authors:  T Nakamura; M F Ghilardi; M Mentis; V Dhawan; M Fukuda; A Hacking; J R Moeller; C Ghez; D Eidelberg
Journal:  Hum Brain Mapp       Date:  2001-01       Impact factor: 5.038

2.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.

Authors:  G W Small; L M Ercoli; D H Silverman; S C Huang; S Komo; S Y Bookheimer; H Lavretsky; K Miller; P Siddarth; N L Rasgon; J C Mazziotta; S Saxena; H M Wu; M S Mega; J L Cummings; A M Saunders; M A Pericak-Vance; A D Roses; J R Barrio; M E Phelps
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Therapeutic high-frequency stimulation of the subthalamic nucleus in Parkinson's disease produces global increases in cerebral blood flow.

Authors:  John J Sidtis; Michele Tagliati; Ron Alterman; Diana Sidtis; Vijay Dhawan; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-05       Impact factor: 6.200

4.  Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease.

Authors:  V Kaasinen; R P Maguire; H-P Hundemer; K L Leenders
Journal:  J Neurol       Date:  2005-10-18       Impact factor: 4.849

5.  Assessment of methylphenidate-induced changes in binding of continuously infused [(11)C]-raclopride in healthy human subjects: correlation with subjective effects.

Authors:  J I Udo de Haes; R Kortekaas; A Van Waarde; R P Maguire; J Pruim; J A den Boer
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

6.  Longitudinal cerebral blood flow changes during speech in hereditary ataxia.

Authors:  John J Sidtis; Stephen C Strother; Ansam Groshong; Ansam Naoum; David A Rottenberg; Christopher Gomez
Journal:  Brain Lang       Date:  2010-04-24       Impact factor: 2.381

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.